Home > Boards > US OTC > Miscellaneous > Therapeutic Solutions International, Inc. (TSOI)

haha and yet again sneaky 0.0001 or 0.0002 off

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Tonneke Member Profile
 
Followed By 2
Posts 581
Boards Moderated 0
Alias Born 10/26/17
160x600 placeholder
Therapeutic Solutions International Reports Inhibition of Microglial Activation with NeuroStilbene InvestorsHub NewsWire - 1/8/2020 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/23/2019 12:02:36 PM
Therapeutic Solutions International Enters into Multi-Million Dollar Master Sales Agreement with WCTE, Inc. InvestorsHub NewsWire - 12/23/2019 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/16/2019 12:54:26 PM
Therapeutic Solutions International Signs Letter of Intent to License Adult Stem Cell Therapy for Treatment of Chronic Trauma... InvestorsHub NewsWire - 12/16/2019 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/12/2019 12:13:37 PM
Therapeutic Solutions International Enters into Multi-Million Dollar Master Sales Agreement with Tiva Bio InvestorsHub NewsWire - 12/12/2019 9:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/20/2019 12:56:29 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 11/14/2019 3:35:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2019 4:05:22 PM
Therapeutics Solutions International Signs Agreement with Beijing Regenesis Biotechnology InvestorsHub NewsWire - 11/11/2019 9:00:00 AM
Therapeutics Solutions International Reports Augmentation of Rejuvenating Activity of Cord Blood Plasma by Pterostilbene InvestorsHub NewsWire - 11/4/2019 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/9/2019 12:59:28 PM
Therapeutic Solutions International Reports NanoStilbene™ Protects the Immune System from Cancer Chemotherapy InvestorsHub NewsWire - 9/9/2019 9:00:00 AM
Feng Lin, MD, Ph.D., Joins Therapeutic Solutions International as Chief Scientific Officer InvestorsHub NewsWire - 9/3/2019 9:00:00 AM
Therapeutic Solutions International, Inc. Reports Revenues Up 850% for Q2 and 850% for 1st 6 months InvestorsHub NewsWire - 8/29/2019 9:00:00 AM
Therapeutic Solutions International Announces Positive Clinical Data Using NanoStilbene™ to Stimulate Immune System InvestorsHub NewsWire - 8/26/2019 9:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/16/2019 4:28:47 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 8/13/2019 1:46:36 PM
Therapeutic Solutions International Collaborates with Right to Try Foundation on Novel Means of Protecting Patients InvestorsHub NewsWire - 8/5/2019 9:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 7/30/2019 4:44:49 PM
NanoStilbene™ Nutraceutical Shown to Increase Ability of Cyclophosphamide Chemotherapy to Suppress Cancer InvestorsHub NewsWire - 7/29/2019 9:00:00 AM
Therapeutic Solutions International Reports its NanoStilbene™ Nutraceutical Product Enhances Efficacy of FDA Cleared Ca... InvestorsHub NewsWire - 7/22/2019 9:00:00 AM
Therapeutic Solutions International adds Nano Cannabidiol to NanoMyros for Inhibition of Microvesicle and Exosome Release InvestorsHub NewsWire - 7/15/2019 9:00:00 AM
Therapeutic Solutions International Develops Adjuvant Technology to Enhance Prostate Cancer Suppressing Properties of InvestorsHub NewsWire - 7/11/2019 9:00:00 AM
Tonneke   Thursday, 10/10/19 02:06:51 PM
Re: None
Post # of 14292 
haha and yet again sneaky 0.0001 or 0.0002 off

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist